UMIN000049746
A Confirmatory Clinical Trial of Two-fractionated Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Prostate Cancer Patients
National Cancer Center·Phase 2·University Hospital Medical Information Network·device·Device trialRecruiting
Study focus
- Disease/Condition
- Prostate cancer
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- National Cancer Center
- Location
- Japan
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Jan 01, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000049746
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for UMIN000049746 through Pure Global AI's free database. This Phase 2 trial is sponsored by National Cancer Center and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.